These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 1396665)
1. Splicing of the platelet-derived-growth-factor A-chain mRNA in human malignant mesothelioma cell lines and regulation of its expression. Langerak AW; Dirks RP; Versnel MA Eur J Biochem; 1992 Sep; 208(3):589-96. PubMed ID: 1396665 [TBL] [Abstract][Full Text] [Related]
2. Regulation of differential expression of platelet-derived growth factor alpha- and beta-receptor mRNA in normal and malignant human mesothelial cell lines. Langerak AW; van der Linden-van Beurden CA; Versnel MA Biochim Biophys Acta; 1996 Feb; 1305(1-2):63-70. PubMed ID: 8605252 [TBL] [Abstract][Full Text] [Related]
3. Identification of regulatory sequences in the promoter of the PDGF B-chain gene in malignant mesothelioma cell lines. Prins JB; Langerak AW; Dirks RP; Van der Linden-Van Beurden CA; De Laat PA; Bloemers HP; Versnel MA Biochim Biophys Acta; 1996 Dec; 1317(3):223-32. PubMed ID: 8988239 [TBL] [Abstract][Full Text] [Related]
4. Expression of c-sis (PDGF B-chain) and PDGF A-chain genes in ten human malignant mesothelioma cell lines derived from primary and metastatic tumors. Versnel MA; Hagemeijer A; Bouts MJ; van der Kwast TH; Hoogsteden HC Oncogene; 1988 Jun; 2(6):601-5. PubMed ID: 3290807 [TBL] [Abstract][Full Text] [Related]
6. Expression of platelet-derived growth factor (PDGF) and PDGF receptors in human malignant mesothelioma in vitro and in vivo. Langerak AW; De Laat PA; Van Der Linden-Van Beurden CA; Delahaye M; Van Der Kwast TH; Hoogsteden HC; Benner R; Versnel MA J Pathol; 1996 Feb; 178(2):151-60. PubMed ID: 8683381 [TBL] [Abstract][Full Text] [Related]
7. Expression of the Wilms' tumor gene WT1 in human malignant mesothelioma cell lines and relationship to platelet-derived growth factor A and insulin-like growth factor 2 expression. Langerak AW; Williamson KA; Miyagawa K; Hagemeijer A; Versnel MA; Hastie ND Genes Chromosomes Cancer; 1995 Feb; 12(2):87-96. PubMed ID: 7535092 [TBL] [Abstract][Full Text] [Related]
8. Modulation of platelet-derived growth factor-beta mRNA expression and cell growth in a human mesothelioma cell line by a hammerhead ribozyme. Dorai T; Kobayashi H; Holland JF; Ohnuma T Mol Pharmacol; 1994 Sep; 46(3):437-44. PubMed ID: 7935323 [TBL] [Abstract][Full Text] [Related]
9. Characterization of platelet-derived growth factor and platelet-derived growth factor receptor expression in asbestos-induced rat mesothelioma. Walker C; Bermudez E; Stewart W; Bonner J; Molloy CJ; Everitt J Cancer Res; 1992 Jan; 52(2):301-6. PubMed ID: 1309438 [TBL] [Abstract][Full Text] [Related]
10. Comparison of production of transforming growth factor-beta and platelet-derived growth factor by normal human mesothelial cells and mesothelioma cell lines. Gerwin BI; Lechner JF; Reddel RR; Roberts AB; Robbins KC; Gabrielson EW; Harris CC Cancer Res; 1987 Dec; 47(23):6180-4. PubMed ID: 3479241 [TBL] [Abstract][Full Text] [Related]
11. Human ovarian tumors of epithelial origin express PDGF in vitro and in vivo. Versnel MA; Haarbrink M; Langerak AW; de Laat PA; Hagemeijer A; van der Kwast TH; van den Berg-Bakker LA; Schrier PI Cancer Genet Cytogenet; 1994 Mar; 73(1):60-4. PubMed ID: 8174076 [TBL] [Abstract][Full Text] [Related]
12. Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-alpha and their receptors in human malignant glioma cell lines. Nistér M; Libermann TA; Betsholtz C; Pettersson M; Claesson-Welsh L; Heldin CH; Schlessinger J; Westermark B Cancer Res; 1988 Jul; 48(14):3910-8. PubMed ID: 2454731 [TBL] [Abstract][Full Text] [Related]
13. Induction of platelet-derived growth factor A and B chains and over-expression of their receptors in human pancreatic cancer. Ebert M; Yokoyama M; Friess H; Kobrin MS; Büchler MW; Korc M Int J Cancer; 1995 Sep; 62(5):529-35. PubMed ID: 7665222 [TBL] [Abstract][Full Text] [Related]
14. Differential expression of platelet derived growth factor-beta in malignant mesothelioma: a clue to future therapies? Pogrebniak HW; Lubensky IA; Pass HI Surg Oncol; 1993 Aug; 2(4):235-40. PubMed ID: 8252214 [TBL] [Abstract][Full Text] [Related]
15. Human malignant fibrous histiocytomas in vitro: growth characteristics and their association with expression of mRNA for platelet-derived growth factor, transforming growth factor-alpha and their receptors. Abdiu A; Walz TM; Nishikawa BK; Wingren S; Larsson SE; Wasteson A Eur J Cancer; 1998 Dec; 34(13):2094-100. PubMed ID: 10070317 [TBL] [Abstract][Full Text] [Related]
16. Paradoxical effects of platelet-derived growth factor-A overexpression in malignant mesothelioma. Antiproliferative effects in vitro and tumorigenic stimulation in vivo. Metheny-Barlow LJ; Flynn B; van Gijssel HE; Marrogi A; Gerwin BI Am J Respir Cell Mol Biol; 2001 Jun; 24(6):694-702. PubMed ID: 11415934 [TBL] [Abstract][Full Text] [Related]
17. Identification of a differential expression of two cDNAs between malignant mesothelioma and normal mesothelial cells using the RNA fingerprint method. Frank S; von Specht BU; Sendt W; Farthmann EH; Hirsch T Tumour Biol; 1998; 19(3):153-9. PubMed ID: 9591041 [TBL] [Abstract][Full Text] [Related]